Replidyne's Reverse Merger Round

Replidyne raised a round of funding on February 25, 2009. Investors include Cardiovascular Systems.

Replidyne is a drug discovery and development firm focused on a new class of antibiotics…

Articles about Replidyne's Reverse Merger Round: